Reuters logo
BRIEF-Crescita Therapeutics reports positive topline results of phase 2 clinical trial to treat plaque psoriasis
September 18, 2017 / 11:56 AM / 3 months ago

BRIEF-Crescita Therapeutics reports positive topline results of phase 2 clinical trial to treat plaque psoriasis

Sept 18 (Reuters) - Crescita Therapeutics Inc

* Crescita Therapeutics reports positive topline results of phase 2 clinical trial for the treatment of plaque psoriasis

* Crescita Therapeutics Inc - ‍trial demonstrated statistical significance in achievement of its primary endpoint​

* Crescita Therapeutics Inc - ‍no unanticipated safety signals were noted in the trial​

* Crescita - phase 2 results to be evaluated in anticipation of end-of-phase 2 meeting with U.S. FDA to discuss advancement to phase 3​

* Crescita Therapeutics Inc - ‍received positive topline results from a phase 2 clinical trial in patients with plaque psoriasis​

* Crescita Therapeutics - licensing revenues would be shared between co and partners; co’s share would reflect its contribution of patented formulations Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below